Prevalence and clinical significance of germline pathogenic variants identified by multigene panel testing in high-risk Japanese patients with breast cancer
Breast Cancer · 2026-07 · 33 (4) · 887-895
DOI: 10.1007/s12282-026-01863-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Breast Cancer, online erschienen am 13.05.2026. Verfasst von Miharu Kano und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Breast Surgery, Department of Surgery, School of Medicine, Showa Medical University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japa…. Hauptthemen laut MEDLINE: Breast Neoplasms, Genetic Predisposition to Disease, Genetic Testing, Germ-Line Mutation. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: SHOWA Medical University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Breast Surgery, Department of Surgery, School of Medicine, Showa Medical University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan.
- Division of Breast Surgery, Department of Surgery, School of Medicine, Showa Medical University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan. ktaruno@med.showa-u.ac.jp.
- Center for Medical Genetics, St. Luke's International Hospital, 9-1 Akashi-cho, Chuo-ku, Tokyo, 104-8560, Japan.
- Department of Breast Surgical Oncology, St. Luke's International Hospital, 9-1 Akashi- cho, Chuo-ku, Tokyo, 104-8560, Japan.
- Department of Breast Surgery, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
- Breast Surgical Oncology, Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
Förderung
- SHOWA Medical University
Zitieren
APA
Kano, M., Taruno, K., Inuzuka, M., Makino, R., Takeuchi, M., Suzuki, M., Kida, K., Takei, J., Nagayama, A., Hayashida, T., Haruyama, Y., Ueno, T., Watanabe, C., Kojima, Y., Sasai, R., Endo, M., Momozawa, Y., & Nakamura, S. (2026). Prevalence and clinical significance of germline pathogenic variants identified by multigene panel testing in high-risk Japanese patients with breast cancer. Breast Cancer, 33(4), 887-895. https://doi.org/10.1007/s12282-026-01863-2
Vancouver
Kano M, Taruno K, Inuzuka M, Makino R, Takeuchi M, Suzuki M, et al. Prevalence and clinical significance of germline pathogenic variants identified by multigene panel testing in high-risk Japanese patients with breast cancer. Breast Cancer. 2026;33(4):887-895. doi:10.1007/s12282-026-01863-2
BibTeX
@article{Kano2026,
author = {Kano, Miharu and Taruno, Kanae and Inuzuka, Mayuko and Makino, Reiko and Takeuchi, Mieko and Suzuki, Misato and Kida, Kumiko and Takei, Junko and Nagayama, Aiko and Hayashida, Tetsu and Haruyama, Yurie and Ueno, Takayuki and Watanabe, Chie and Kojima, Yasuyuki and Sasai, Rumi and Endo, Mikiko and Momozawa, Yukihide and Nakamura, Seigo},
title = {Prevalence and clinical significance of germline pathogenic variants identified by multigene panel testing in high-risk Japanese patients with breast cancer},
journal = {Breast Cancer},
year = {2026},
volume = {33},
number = {4},
pages = {887--895},
doi = {10.1007/s12282-026-01863-2}
}
EUVIMED